374 related articles for article (PubMed ID: 31407167)
1. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
[TBL] [Abstract][Full Text] [Related]
2. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
3. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
4. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer.
Fujita S; Yamamoto S; Akasu T; Moriya Y
Int J Colorectal Dis; 2009 Sep; 24(9):1085-90. PubMed ID: 19387660
[TBL] [Abstract][Full Text] [Related]
6. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
7. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T
Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189
[TBL] [Abstract][Full Text] [Related]
8. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
[TBL] [Abstract][Full Text] [Related]
9. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis.
Fujita S; Yamamoto S; Akasu T; Moriya Y
Hepatogastroenterology; 2012; 59(120):2494-7. PubMed ID: 22534546
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study.
Inoue H; Sasaki K; Nozawa H; Kawai K; Murono K; Emoto S; Iida Y; Ishii H; Yokoyama Y; Anzai H; Sonoda H; Ozaki K; Yamauchi S; Sugihara K; Ishihara S
Int J Colorectal Dis; 2021 Jun; 36(6):1263-1270. PubMed ID: 33537876
[TBL] [Abstract][Full Text] [Related]
12. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
[TBL] [Abstract][Full Text] [Related]
13. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
[TBL] [Abstract][Full Text] [Related]
14. Lateral pelvic lymph node dissection using latero-vesical approach with aspiration procedure for advanced lower rectal cancer.
Kawahara H; Watanabe K; Ushigome T; Yanagisawa S; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012; 59(113):116-9. PubMed ID: 21940358
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer.
Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T
World J Surg Oncol; 2022 Sep; 20(1):281. PubMed ID: 36057660
[TBL] [Abstract][Full Text] [Related]
16. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
[TBL] [Abstract][Full Text] [Related]
17. Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective.
Choi SH; Chang JS; Yoon HI; Jang DS; Kim NK; Lim JS; Min BS; Huh H; Shin SJ; Ahn JB; Koom WS
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1119-1128. PubMed ID: 29546480
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
[TBL] [Abstract][Full Text] [Related]
19. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
[TBL] [Abstract][Full Text] [Related]
20. Lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation: can it be a powerful supplement tool for predicting the status of lateral pelvic lymph nodes in advanced lower rectal cancer.
Su H; Xu Z; Bao M; Luo S; Liang J; Pei W; Guan X; Liu Z; Jiang Z; Zhang M; Zhao Z; Jin W; Zhou H
Surg Endosc; 2023 May; 37(5):4088-4096. PubMed ID: 36997652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
